I

InBody

Manufactures professional body composition analyzers

Overview

InBody designs and manufactures professional body composition analyzers that measure muscle mass, body fat, and total body water using Direct Segmental Multi-Frequency BIA (DSM-BIA). The devices send safe electrical signals and analyze resistance and reactance in separate body segments, with results stored and analyzed in LookinBody Web in the cloud for clinics, gyms, and researchers. Its segmental DSM-BIA approach yields more accurate measurements than traditional one-number BIA and is supported by FDA clearance and partnerships like GE Healthcare. The company aims to provide precise, accessible body composition data worldwide to help health professionals monitor changes and create new revenue streams through testing services.

Significant Headcount Growth

Work here?Claim your company

About InBody

Simplify's Rating
Why InBody is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

501-1,000

Company Stage

IPO

Headquarters

Seoul, South Korea

Founded

1996

Get referred to InBody

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Q3 2026 revenue rose 19.2% to KRW 71.3 billion, driven by the U.S.
  • InBody China won GLP-1 pharmacy and hospital contracts across China's weight-management rollout.
  • HYROX North America named InBody its Official Body Composition and Performance Partner on 2026-07-14.

What critics are saying

  • Kiwoom said Q3 2026 operating profit included foreign-exchange and inventory accounting boosts.
  • Domestic revenue fell 15% in Q3 2026, exposing weak Korean professional-device demand.
  • A prolonged GLP-1 slowdown and cheaper competitors erase InBody's premium positioning.

What makes InBody unique

  • InBody's DSM-BIA measures body segments separately, avoiding demographic estimation shortcuts.
  • Naver bought 1.15 million treasury shares on 2026-11-03, linking InBody to AI healthcare.
  • InBody University launched CEU-approved training, deepening stickiness with 10 million professionals.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$23M

Above

Industry Average

Funded Over

1 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Wellness Program

Stock Price

Growth & Insights and Company News

6 month growth

5%

1 year growth

43%

2 year growth

43%
MoneyToday
Oct 25th, 2026
From video production to medical devices: a string of early-stage investments, plus late-stage proptech mega-deals - MoneyToday

[For more diverse corporate information on the startups mentioned in this article, please refer to the 'Data Lab' of the Unicorn Factory big data platform .] Graphic = Im Jong-cheol A total

PR Newswire
Oct 8th, 2026
Inglewood launches $400K fall prevention pilot to become America's second Blue Zone city

Inglewood has launched a one-year fall prevention pilot programme backed by approximately $400,000 in city funding, deploying InBody's Fall Risk Assessment system for seniors. The initiative, developed with the University of Southern California, supports the city's goal of becoming America's second Blue Zone city. The FRA system integrates three devices: a force-plate kiosk for balance analysis, a body composition analyser to identify muscle imbalances, and a leg-strength dynamometer. It will be deployed at Inglewood's Senior Center through KRU Sciences, a research company founded by USC researcher Malcolm Jones. Falls are the leading cause of injury-related death among US adults aged 65 and older, contributing over $50 billion in annual healthcare costs. More than 80% of fall risk factors are detectable months before a fall occurs. The Inglewood City Council unanimously approved the programme following advocacy from USC clinicians and community support.

PR Newswire
Mar 19th, 2026
InBody launches University with approved continuing education units for health professionals

InBody, a bioelectrical impedance analyzer company, is launching InBody University (IBU), the first platform in its industry to offer approved continuing education units to customers. The on-demand professional development platform targets health, fitness and wellness professionals. IBU will feature over 150 educational videos covering topics from basic body composition interpretation to advanced clinical applications and client communication strategies. The platform offers CEU-approved content recognised by leading health and wellness organisations. InBody has partnered with the International Sports Sciences Association to provide continuing education, supporting ISSA's goal to connect 100 million people to healthy living by 2030. The company plans to expand the platform with additional courses aligned with industry needs. InBody serves over 10 million professionals across medical, fitness, research and corporate wellness settings worldwide.

Wow Partners, Inc.
Nov 26th, 2025
Naver Acquires Cenacle for Cloud EMR

Naver Cloud has increased its investment in Cenacle, securing a majority stake. The acquisition amount remains undisclosed. Cenacle offers cloud EMR services like 'Orem Chart' and patient health apps, targeting various medical fields. Recognized as a top health tech company for 2025, Cenacle aims to enhance AI-driven medical support and service stability with Naver. Naver is also collaborating with other healthcare firms to advance its platform and global reach.

Maeil Business News Korea
Oct 30th, 2025
Naver Acquires InBody Shares for $23M

Naver Corp. acquired 1.15 million treasury shares of InBody Co. for 32.5 billion won ($23 million), becoming its fourth-largest shareholder. The purchase, at 28,350 won per share, represents 8.5% of InBody's total shares. This strategic partnership aims to enhance Naver's global digital healthcare business. The collaboration will integrate InBody's body composition analysis technology with Naver's AI capabilities, strengthening their influence in the digital healthcare industry.

Recently Posted Jobs

Sign up to get curated job recommendations

InBody is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs